Navigation Links
Ovation further advances development pipeline with new phase III epilepsy study
Date:9/4/2007

DEERFIELD, Ill., September 4, 2007 OVATION Pharmaceuticals, Inc. announced the initiation of a pivotal Phase III clinical trial evaluating clobazam, a unique 1,5 benzodiazapine with significant anticonvulsant properties, as adjunctive treatment for patients with Lennox-Gastaut syndrome (LGS), one of the most severe forms of childhood epilepsy that frequently persists into adulthood. In previous studies clobazam was shown to be well tolerated in patients with LGS and met the primary endpoint in a Phase II dose range finding study of a significant reduction in drop (or atonic) seizures compared to baseline. Drop seizures are the most debilitating of the LGS seizures types, which can result in severe trauma to the brain and body. This latest study demonstrates OVATIONs progress in advancing its central nervous system (CNS) development pipeline.

LGS, like many catastrophic epilepsies, can be both devastating and overwhelming for patients and their families, and clobazam may offer improved seizure control for patients affected by this condition, said Stephen D. Collins M.D., Ph.D., Chief Scientific Officer and Vice President of Clinical Affairs, Ovation Pharmaceuticals. OVATION remains committed to exploring new treatment options for epilepsy, particularly where current treatment needs are not fully addressed.

The Phase III study is designed to evaluate the safety and efficacy of clobazam in the reduction of atonic seizures at three dose levels in children and adults (ages 2-60 years) with LGS. The company plans to recruit patients with LGS at approximately 60-65 sites. The double-blind, placebo-controlled study will last up to 23 weeks. For more information and study locations, please visit www.clinicaltrials.gov.

"LGS is one of the most severe forms of epilepsy and we desperately need new treatment options," said Eric R. Hargis, President and CEO of the Epilepsy Foundation. "We hope that the Phase III study shows great results and that
'/>"/>

Contact: Nikki Nelson
nikki.nelson@edelman.com
312-565-2183
Edelman Public Relations
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Genetic innovation
2. Biocon To Shift Focus On Innovation To Accelerate Growth
3. IIT Delhi To Display Its Technological Innovations In Open House
4. Patent for Seminal RNAi innovation Cleared in Australia
5. Innovation Needed In The Field Of Diagnostics: Nair
6. A young scientist recognized for biomechanics innovations
7. Blood Safety, Supply, and Innovations Addressed at Conference
8. New Innovation in Clubfoot Treatment
9. Further support for use of statins in Alzheimer’s disease
10. Clinical Impact of Activity and Abdominal Pressure on Pelvic Floor Dysfunction Need to Be Further Analyzed
11. Doctor Accused Of Misdiagnosing 208 Patients: Further Investigation Ordered
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... adherence to appropriate medication therapy has been shown to ... 125,000 deaths in the U.S. every year are attributed ... estimated that between 33% and 69% of all medication-related ... a reality that costs the American health-care system approximately ... degree of medication non-adherence — and the consequences therefrom ...
(Date:5/22/2013)... Those who have already gone through a lap ... hardest work is yet to come. As of April 24, ... have special health needs that should be addressed in nutrition ... Surgery” abclocal.go.com/kabc/story?section=news/food_coach&id=9078455). Bariatric surgeon Dr. Madan offers four tips to ... can be lost and kept off. , First, lap ...
(Date:5/22/2013)... SAN DIEGO, CA (PRWEB) May 22, 2013 ... active lifestyle media and publishing company released today ... The 10 healthiest business hotels received the company’s ... traveler feedback, and anonymous personal tours by the ... multi-sport options (e.g., lap pool, sport court, etc.), ...
(Date:5/21/2013)... (PRWEB) May 22, 2013 The University ... teaming up with HEALTHY DINING to help Coloradans make ... , The new program is called HEALTHY DINING IN ... locations are already participating in Colorado. Restaurants will offer ... and adults emphasizing lean protein, vegetables, fruits, whole grains ...
(Date:5/21/2013)... Swimsuit season is almost here. The "Get Ready ... begun with a 35% discount. , Cellulite forms mainly in ... the dreaded cellulite even if they are in shape. ... have been stored as toxic lymph and smashed together, giving ... specific program that works to dissolve the toxins and fatty ...
Breaking Medicine News(10 mins):Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2Health News:The Lap Band Center: Dr. Atul Madan Offers Five Tips for Ongoing Weight Loss for Lap Band Patients 2Health News:The Lap Band Center: Dr. Atul Madan Offers Five Tips for Ongoing Weight Loss for Lap Band Patients 3Health News:2013: The 10 Healthiest Business Hotels in the U.S. 2Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 2Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 3Health News:Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale" 2
... Research is pleased to announce that CR AACR,s ... won first place in the 2011 National Media Awards ... Separately, it received three additional awards from the Greater ... "We are honored and humbled to receive ...
... with an increased risk of adverse pregnancy outcomes, suggests ... 13, in Minneapolis, Minn., at SLEEP 2011, the 25th ... (APSS). Results show that women with severe sleep ... This increased prevalence was principally driven by a ...
... Clinical & Experimental Allergy reveals that keeping a ... risk of becoming allergic to the pets. Parents of young ... cat in their home will increase the risk of their ... MS, PhD, of the Department of Public Health Sciences, Henry ...
... senior patients within 30 days of discharge from ... in recent years, at an estimated annual cost ... from Hebrew Rehabilitation Center (HRC), an affiliate of ... following a three-pronged intervention that combines standardized admission ...
... Goodwin HealthDay Reporter , FRIDAY, June 10 ... coffee cups and take-out containers, has been added to ... to a new U.S. government report. On Friday, ... Services added styrene, along with five other chemicals -- ...
... SATURDAY, June 11 (HealthDay News) -- For most people, insect ... for those who are allergic to them, researchers warn. ... million people have to go to emergency departments after suffering ... American College of Allergy, Asthma and Immunology, which recently released ...
Cached Medicine News:Health News:AACR's CR magazine honored with 4 prestigious journalism awards 2Health News:Sleep apnea may increase the risk of adverse pregnancy outcomes 2Health News:Reducing avoidable rehospitalizations among seniors 2Health News:Reducing avoidable rehospitalizations among seniors 3Health News:Chemical Found in Foam Cups a Possible Carcinogen 2Health News:Chemical Found in Foam Cups a Possible Carcinogen 3Health News:Insect Stings Hold Deadly Risk for Some 2
(Date:5/21/2013)...  Lakeland Industries, Inc. (NASDAQ: LAKE ... clothing for industry, municipalities, healthcare and first responders ... announced that the Company accepted a commitment letter ... subject to certain terms and conditions and is ... assurances can be given that this transaction or ...
(Date:5/21/2013)... 21 de mayo de 2013 La junta ... filiales incluyen OMNIlife science®, Inc., Enztec, Ltd. y Praxim, ... su junta. Guy Mayer, un ejecutivo ortopédico experimentado, será ... David Johnson , un experto refutado en ... Antes de unirse a OSI como presidente de ...
(Date:5/21/2013)... CINCINNATI , May 21, 2013  LCA-Vision Inc. (NASDAQ: ... correction services under the Lasik Plus ® brand, announces that ... to one-year terms at today,s annual meeting of stockholders.  These ... , co-founder and President of Bahl & Gaynor Investment Counsel ... with BSC Ventures , Edgar F. Heizer ...
Breaking Medicine Technology:Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 2Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 3Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 4Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 5Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 6Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 7Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 8Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 9Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 10Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 11Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 12Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 13Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 2Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 3LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4
... 4Q07/1Q08, DALLAS, Aug. 20 Access Pharmaceuticals, ... on the clinical,development plan of ProLindac, its novel ... human clinical trials to be initiated in,late 2007/ ... ovarian,cancer patients, designed to optimize single agent dosing ...
... in the journal Blood found 92 percent reduction in ... ... Patients with a rare,blood disorder called PNH experienced a ... following treatment,with Soliris(TM) (eculizumab), according to an analysis of clinical ...
Cached Medicine Technology:Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 2Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 3Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 2PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 3PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 5PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 6PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 7PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 8
... order products are offered as 1-piece or ... The modular instruments may be customized with ... as ratchets, insulation and flush ports. Many ... Customer specifications may affect delivery times. ...
... offered as 1-piece or modular, in regular ... may be customized with handles of choice ... and flush ports. Many standard patterns are ... affect delivery times. , Please Note: ...
... products are offered as 1-piece or modular, ... modular instruments may be customized with handles ... ratchets, insulation and flush ports. Many standard ... specifications may affect delivery times. , ...
... Featured Products are kept ... and are offered as ... regular or extra long ... with insulation, flush ports, ...
Medicine Products: